Sign in

CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474272481
Phone
650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Option exercise Chief Financial Officer acquired 21,000 shares (option exercise)
  9. 4 Grant or award Chief Medical Officer acquired 42,900 shares (grant or award)
  10. 4 Grant or award Chief Business Officer acquired 31,500 shares (grant or award)
  11. 4 Grant or award General Counsel & Corp. Sec'y acquired 31,500 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 55,250 shares (grant or award)
  13. 4 Grant or award Chief Human Resource Officer acquired 26,000 shares (grant or award)
  14. 4 Grant or award President and CEO acquired 128,150 shares (grant or award)
  15. 4 Planned sale Chief Financial Officer sold 9,781 shares at $17.23 ($168,527)
  16. 4 Planned sale Chief Business Officer sold 9,786 shares at $17.23 ($168,613)
  17. 4 Planned sale President and CEO sold 25,721 shares at $17.23 ($443,173)
  18. 4 Planned sale Chief Medical Officer sold 10,295 shares at $17.23 ($177,383)
  19. 4 Planned sale General Counsel & Corp. Sec'y sold 5,197 shares at $17.23 ($89,544)
  20. 4 Planned sale Chief Business Officer sold 33,119 shares at an average $20.01 ($662,581)

Page 4 of 11 · 215 filings